The Valens Company Inc (VLNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VLNS | ABT | MDT | SYK | BSX |
| Company | The Valens Company Inc | Abbott Laboratories | Medtronic Inc | Stryker Corp | Boston Scientific Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 0.7512 | 106.71 | 80.77 | 335.28 | 73.14 |
| High | 0.7745 | 107.11 | 80.83 | 342.60 | 74.39 |
| Low | 0.7479 | 105.56 | 80.01 | 334.20 | 72.55 |
| Last | 0.7602 | 106.89 | 80.38 | 336.85 | 72.91 |
| Change | +0.0002 | -0.70 | -0.91 | +1.94 | +3.92 |
| % Change | +0.03% | -0.65% | -1.12% | +0.58% | +5.68% |
| Volume | 44,600 | 5,052,600 | 5,028,800 | 1,515,600 | 15,276,400 |
| 20-Day Average Volume | 174,735 | 5,704,210 | 6,289,945 | 1,151,585 | 6,347,430 |
| Previous Close | 0.7600 | 107.59 | 81.29 | 334.91 | 68.99 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6990 | 109.83 | 82.53 | 343.58 | 68.41 |
| 20-Day Raw Stochastic | 73.96% | 27.02% | 20.97% | 36.64% | 80.50% |
| 20-Day Relative Strength | 51.25% | 39.34% | 41.38% | 44.85% | 71.24% |
| Weighted Alpha | -63.26 | -2.42 | -9.74 | +16.16 | +48.58 |
| Today's Opinion | 56% Sell | 8% Sell | 40% Sell | 40% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 8% Buy | 24% Sell | 40% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 56% Buy | 40% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.83% since 01/06/23 | +0.93% since 04/17/24 | +1.64% since 04/17/24 | +0.24% since 04/17/24 | +7.28% since 04/17/24 |
| Low | 0.6802 on 01/09/23 | 104.47 on 04/18/24 | 78.43 on 04/18/24 | 323.75 on 04/22/24 | 66.80 on 04/22/24 |
| High | 0.7745 on 01/13/23 | 108.11 on 04/23/24 | 81.34 on 04/23/24 | 342.60 on 04/24/24 | 74.39 on 04/24/24 |
| 1-Month | |||||
| %Chg | -5.88% since 12/13/22 | -3.33% since 03/22/24 | -3.25% since 03/22/24 | -4.47% since 03/22/24 | +7.82% since 03/22/24 |
| Low | 0.6000 on 01/03/23 | 104.25 on 04/17/24 | 78.43 on 04/18/24 | 323.75 on 04/22/24 | 66.80 on 04/22/24 |
| High | 0.8166 on 12/22/22 | 114.02 on 03/28/24 | 87.73 on 03/28/24 | 359.50 on 03/28/24 | 74.39 on 04/24/24 |
| 3-Month | |||||
| %Chg | +13.38% since 10/13/22 | -3.50% since 01/24/24 | -5.12% since 01/24/24 | +9.46% since 01/24/24 | +21.68% since 01/24/24 |
| Low | 0.6000 on 01/03/23 | 104.25 on 04/17/24 | 78.43 on 04/18/24 | 307.23 on 01/25/24 | 59.97 on 01/25/24 |
| High | 1.0900 on 12/05/22 | 121.64 on 03/08/24 | 89.18 on 01/31/24 | 361.41 on 03/11/24 | 74.39 on 04/24/24 |
| 6-Month | |||||
| %Chg | +6.50% since 07/13/22 | +12.74% since 10/24/23 | +11.70% since 10/24/23 | +27.08% since 10/24/23 | +43.07% since 10/24/23 |
| Low | 0.6000 on 01/03/23 | 91.64 on 10/30/23 | 68.84 on 10/30/23 | 255.22 on 10/26/23 | 49.15 on 10/27/23 |
| High | 1.2600 on 08/16/22 | 121.64 on 03/08/24 | 89.18 on 01/31/24 | 361.41 on 03/11/24 | 74.39 on 04/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 61,379 | 186,688,448 | 107,938,728 | 127,423,208 | 101,214,952 |
| Shares Outstanding, K | 80,740 | 1,735,184 | 1,327,823 | 380,470 | 1,467,096 |
| Annual Sales | 62,360,000 | 40,109,000,000 | 31,227,000,000 | 20,498,000,000 | 14,240,000,000 |
| Annual Net Income | -39,110,000 | 5,723,000,000 | 3,758,000,000 | 3,165,000,000 | 1,591,000,000 |
| Last Quarter Sales | 15,750,000 | 9,964,000,000 | 8,089,000,000 | 5,815,000,000 | 3,725,000,000 |
| Last Quarter Net Income | -21,360,000 | 1,225,000,000 | 1,322,000,000 | 1,143,000,000 | 503,000,000 |
| 60-Month Beta | N/A | 0.74 | 0.76 | 0.89 | 0.78 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 10/13/22 | 0.98 on 04/17/24 | 1.30 on 02/20/24 | 3.46 on 01/30/24 | 0.55 on 01/31/24 |
| Latest Earnings Date | 02/27/23 | 04/17/24 | 05/23/24 | 04/30/24 | 04/24/24 |
| Most Recent Dividend | N/A | 0.550 on 04/12/24 | 0.690 on 03/21/24 | 0.800 on 03/27/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/12/24 | 03/21/24 | 03/27/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.39 | 15.14 | 30.91 | 33.18 |